Quality of life in patients with midgut NET following peptide receptor radionuclide therapy.
Milka MarinovaMartin MückeFelix FischerMarkus EsslerHenning CuhlsLukas RadbruchShiwa GhaeiRupert ConradHojjat AhmadzadehfarPublished in: European journal of nuclear medicine and molecular imaging (2019)
Our study confirmed an equally positive effect of PRRT on quality of life in midgut NET patients with high or moderate functional status in terms of increasing global health, functional status, and alleviating symptoms.